Virtual Neuro-Navigation System for Personalized Community-Based TMS
Study Investigating a Treatment for Depression in Patients with Major Depressive Disorder (MDD)
Sponsor: Soterix Medical
Enrolling: Male and Female Patients
Study Length: 2 Months
IRB Number: AAAU2047
U.S. Govt. ID: NCT04956081
Contact: Rashel Mejia: / rashel.mejia@nyspi.columbia.edu
Additional Study Information: Are you suffering from chronic depression? We are seeking participants for a depression treatment research study at Columbia University using Transcranial Magnetic Stimulation (TMS). This study develops a more accurate TMS to treat chronic depression. Participation includes clinical assessments and magnetic resonance imaging (MRI). You will receive 27 sessions of TMS treatment over up to 8 weeks.
Investigator
Joshua Berman, MD, PhD
Do You Qualify?
Are you diagnosed with Major Depressive Disorder (MDD)? Yes No
Do you live in NYC / Can you comfortably travel to NYC for the duration of the study? Yes No
Are you currently pregnant or breastfeeding? Yes No
Can you commit to daily TMS treatment, 5-days a week? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Rashel Mejia
rashel.mejia@nyspi.columbia.edu